Clinical Briefs for Friday, January 17
Sleep aid approved for general population may treat insomnia in Alzheimer’s … Probiotic drink could combat antibiotic resistance, say researchers … Eye movement test confirms loss of inhibition in aging
Alzheimer’s Disease
Clinical Briefs for Tuesday, January 14
Biogen to acquire early-stage Alzheimer’s, Parkinson’s treatment from Pfizer … Flu activity is high, but related deaths and hospitalizations remain low: CDC … Most people with osteoporosis get knee replacement timing all wrong, study finds … Protein tied to ovarian cancer aggravates neurodegeneration in Alzheimer’s
Clinical Briefs for Friday, January 10
Metabolic syndrome associated with blood clot recurrence … Rural patients more likely to remain longer in post-acute care … Nurses — again — ranked as the most ethical, honest … Discovery: Drug-like compounds that may protect brain cells in Alzheimer’s
Brain injury risk spikes when Alzheimer’s patients are treated with antipsychotics
Antipsychotics are associated with greater odds of head injury and traumatic brain injury, according to a new Finnish study.
Clinical Briefs for Thursday, January 9
Teva to pay $54 million to settle False Claims Act lawsuit involving Parkinson’s drug … Non-antibiotic wound gel treats and prevents infections … Company licenses voice biomarkers for Alzheimer’s … Are we cooler than our great grandparents? Human body temperature decreases in U.S.
Residents with Alzheimer’s prefer emotionally meaningful pursuits, study finds
Residents with Alzheimer’s disease prefer emotionally meaningful, familiar pursuits over task-oriented activities, a new study finds.
PPIs do not raise dementia risk, review finds
There is no link between a common class of acid reflux medications and increased dementia risk, according to a new analysis.
Do you want to know that you’ll develop Alzheimer’s? For many, the answer is yes
Most adults want to know that they have Alzheimer’s disease before symptoms appear, finds a UK survey. And 75% are willing to be tested.
Subtle cognitive problems may reveal Alzheimer’s far earlier than thought
Amyloid plaques accumulated faster in the brains of people who showed subtle difficulties in memory and learning tests.
Clinical Briefs for Friday, December 20
Alzheimer’s initiative aims to enhance clinical care … FDA proposes rule allowing drugs to be imported from Canada … New Parkinson’s drug meets safety criteria in mid-stage trial … Medicinal cannabis substitute may treat side effects of Parkinson’s drugs
Next post in Clinical Daily News
